drugset

drugset / Trial / NCT00368576

A Study To Determine The Effect Of SB-480848 On Asthma

NCT00368576 ↗

Phase 1 Completed 67 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this study is to compare the effects of SB-480848 with placebo in subjects with asthma.

Timeline

Start: 2006-08
Primary completion: 2007-10
Completion: 2007-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Darapladib	Small molecule	—	—

Indications